The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American Indian/Alaska Native populations, and persons experiencing homelessness.
Continuing Medical Education and Continuing Education (CME/CE) offered at NO COST. The registration link will direct you to the UCLA ISAP Learning Center. If you are new to the Learning Center, please select “Register Now”, and you will be directed to create a New Learner account. Your profile must include your degree, profession, and license number to claim continuing education credit corresponding to your licensure/certification. Once you create an account, your information will be saved, and the training will appear under My Courses, where you can access the meeting link. You will also receive an email with the meeting link prior to the training.